Currently predicting for Mon, 1 Apr 2024

Trading levels for EXEL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 24.75 4.30 %
R2 24.26 2.24 %
R1 23.96 0.96 %
Current price: 23.73
Support S1 22.98 -3.16 %
S2 22.68 -4.43 %
S3 22.19 -6.49 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 23.92 0.80 %
R2 23.78 0.211 %
R1 23.74 0.0421 %
Current price 23.73
Support S1 22.54 -5.01%
S2 22.09 -6.91%
S3 20.39 -14.08%

EXEL Predictions History

1 year ago
larrybirch14.312433 predicted that EXEL for 2022-04-01 is going

Rank:

2 years ago
JS predicted that EXEL for 2021-11-15 is going

2 years ago
JS predicted that EXEL for 2021-11-15 is going $18.20 (0.72%)

2 years ago
valentin.burtea predicted that EXEL for 2021-11-15 is going

Rank:

2 years ago
JS predicted that EXEL for 2021-09-02 is going $19.81 (-2.27%)

2 years ago
stevendobbelaere predicted that EXEL for 2021-09-02 is going

Rank:

2 years ago
JS predicted that EXEL for 2021-06-22 is going $22.87 (0.18%)

2 years ago
kyle.cuschieri.17.239611 predicted that EXEL for 2021-06-04 is going $28.00 (25.17%)

Rank:

3 years ago
JS predicted that EXEL for 2020-10-19 is going $23.21 (2.84%)

3 years ago
JS predicted that EXEL for 2020-10-12 is going $23.65 (-1.38%)

Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT